Targeting the pathogenic role of interleukin 1{beta} in the progression of smoldering/indolent myeloma to active disease.
Dinarello
Charles A
CA
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000494:pharmacology / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000032:analysis / Q000096:biosynthesis; D009101:Multiple Myeloma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D015850:Interleukin-6